Spago Nanomedical terminates liquidity guarantee

Spago Nanomedical AB (publ) today announced that the company has terminated its liquidity guarantee agreement with Erik Penser Bank AB. The volumes in the share trading are deemed to be sufficient to ensure satisfactory liquidity even without a guarantee, and the termination gives the opportunity for more efficient cost allocation to benefit the company’s development projects. The liquidity guarantee thus ends after December 31, 2022. The management intends to follow how the liquidity of the share develops over time in order to be able to take measures that strengthen liquidity if necessary.